Research Article
Aflibercept Intervention in Experimental Branch Retinal Vein Occlusion Results in Upregulation of DnaJ Homolog Subfamily C Member 17
Table 1
Proteins which were regulated following aflibercept intervention in experimental BRVO.
| Protein ID | Protein name | value | Fold change |
| P35968 | Vascular endothelial growth factor receptor 2 (aflibercept) | 0.000016 | 64.64 | Q9NVM6 | DnaJ homolog subfamily C member 17 | 0.0011 | 6.19 | Q9BXK5-2 | Isoform 1 of Bcl-2-like protein 13 | 0.0075 | 1.59 | P12268 | Inosine-5-monophosphate dehydrogenase 2 | 0.0070 | 1.52 | Q9H0D6-2 | Isoform 2 of 5-3 exoribonuclease 2 | 0.0082 | 1.47 | Q9UPQ0-10 | Isoform 10 of LIM and calponin homology domains-containing protein 1 | 0.0070 | 1.37 | Q8WZA9 | Immunity-related GTPase family Q protein | 0.0022 | 1.36 | P63208-2 | Isoform 2 of S-phase kinase-associated protein 1 | 0.0086 | 1.35 | Q6Q7J2 | Rab GDP dissociation inhibitor beta | 0.0041 | 0.86 | P62191 | 26S proteasome regulatory subunit 4 subunit 4 | 0.0098 | 0.71 | P20585 | DNA mismatch repair protein Msh3 | 0.0077 | 0.66 | Q29195 | 60S ribosomal protein L10 | 0.0088 | 0.61 | Q16891-3 | Isoform 3 of MICOS complex subunit MIC60 | 0.0053 | 0.52 | Q9UN36-2 | Isoform 2 of protein NDRG2 | 0.00070 | 0.40 |
|
|